Myriad Genetics, Inc. (MYGN)

Myriad Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020
Cash & Equivalents	99.9	132.1	56.9	257.4	117	163.7
Short-Term Investments	-	8.8	58	81.4	33.7	54.1
Cash & Short-Term Investments	99.9	140.9	114.9	338.8	150.7	217.8
Cash Growth	15.76%	22.63%	-66.09%	124.82%	-30.81%	59.09%
Accounts Receivable	125.7	114.3	101.6	91.3	89.5	68.1
Other Receivables	-	-	-	-	-	2.9
Receivables	125.7	114.3	101.6	91.3	89.5	71
Inventory	26.2	22	20.1	15.3	27.1	29.1
Prepaid Expenses	41.4	35.2	36	39.4	122.1	13.8
Restricted Cash	-	1.2	2	-	-	-
Total Current Assets	293.2	313.6	274.6	484.8	389.4	331.7
Property, Plant & Equipment	172.8	180.6	187.3	125.3	100.4	103
Long-Term Investments	-	-	54.8	59	21	37
Goodwill	286.3	287.4	286.8	239.2	329.2	327.6
Other Intangible Assets	312.5	354.1	386.8	410.8	578.8	605.3
Other Long-Term Assets	16.5	10.8	8.4	1.6	-	-
Total Assets	1,081	1,147	1,199	1,321	1,419	1,405
Accounts Payable	29.6	25.8	28.8	29.6	20.5	21.7
Accrued Expenses	77.5	75.7	70.2	82.7	62.1	61.5
Current Portion of Leases	13.5	16.2	14.1	13	13.6	13.5
Current Income Taxes Payable	4.2	4.6	4.8	4	4.3	6.1
Current Unearned Revenue	-	-	-	-	32.7	32.8
Other Current Liabilities	29.5	33.6	19.3	75	12.7	11.4
Total Current Liabilities	154.3	155.9	137.2	204.3	145.9	147
Long-Term Debt	39	38.5	-	-	224.8	224.4
Long-Term Leases	90.6	97.4	130.9	79.3	50.6	56.9
Long-Term Deferred Tax Liabilities	-	-	-	35.8	71.3	26.6
Other Long-Term Liabilities	65.7	71.5	44.8	33.5	45.2	31.5
Total Liabilities	349.6	363.3	312.9	352.9	537.8	486.4
Common Stock	0.9	0.9	0.8	0.8	0.8	0.7
Additional Paid-In Capital	1,445	1,416	1,260	1,226	1,110	1,097
Retained Earnings	-714.3	-629.5	-366.2	-254.2	-227	-173.9
Comprehensive Income & Other	-0.1	-3.7	-8.9	-5.1	-2.3	-5.2
Total Common Equity	731.7	783.2	885.8	967.8	881	918.2
Shareholders' Equity	731.7	783.2	885.8	967.8	881	918.2
Total Liabilities & Equity	1,081	1,147	1,199	1,321	1,419	1,405
Total Debt	143.1	152.1	145	92.3	289	294.8
Net Cash (Debt)	-43.2	-11.2	24.7	305.5	-117.3	-40
Net Cash Growth	-	-	-91.91%	-	-	-
Net Cash Per Share	-0.48	-0.14	0.31	3.92	-1.57	-0.54
Filing Date Shares Outstanding	91.04	89.87	81.22	80.02	76.3	74.71
Total Common Shares Outstanding	91	89.9	81.2	80	75.4	74.7
Working Capital	138.9	157.7	137.4	280.5	243.5	184.7
Book Value Per Share	8.04	8.71	10.91	12.10	11.68	12.29
Tangible Book Value	132.9	141.7	212.2	317.8	-27	-14.7
Tangible Book Value Per Share	1.46	1.58	2.61	3.97	-0.36	-0.20
Machinery	154.5	147.6	124.7	112.4	117.9	112.1
Leasehold Improvements	78.2	91.3	67.9	38	35.7	31.8

Source: S&P Capital IQ. Standard template. Financial Sources.